2bPrecise, an Allscripts company, launches a Genomics and Precision Medicine Initiative at National Institutes of Health
August 08 2016 - 8:01AM
2bPrecise LLC, a wholly owned subsidiary of Allscripts Healthcare
Inc. (Allscripts) (NASDAQ:MDRX), has launched a strategic early
adopter program at the National Institutes of Health (NIH),
America’s leading Care Institution for clinical research and a
long-time Allscripts Sunrise™ client. The program will focus on
deploying a cloud-based genomics and precision medicine solution
designed by 2bPrecise.
The 2bPrecise EHR Agnostic solution will enable
physicians and researchers to use genomic information in their
current Allscripts Sunrise™ workflow, simplifying and optimizing
the complex process of finding, selecting, ordering and receiving
genomic tests. Using the 2bPrecise genomics and precision medicine
solution, results of genomic sequencing tests will be made
available and actionable at the point of care through Allscripts
Sunrise™ electronic health record (EHR).
Experts from NIH in the field of genomic medicine
will be the early adopters of the 2bPrecise solution. Users of the
program will pan across the National Human Genome Research
Institute, the National Cancer Institute and the NIH Clinical
Center.
“We are honored and excited to work with NIH, one
of the most innovative research institutions in the world, on this
dimensional change of health care. 2bPrecise will soon be
able to take a big step toward bringing an easy-to-use,
clinical-genomic solution into the mainstream,” said 2bPrecise
General Manager Assaf Halevy. Soon, this solution offering will be
available to any provider, integrated delivery network or payer
organization who wants to advance the research that will unlock new
insights of molecular diagnostics and new treatments.
In addition to improving the workflow experience
for physicians and nurses, the 2bPrecise solution uses advanced
methods in clinical-genomic ontology and data harmonization and
will return merged, semantically harmonized knowledge in a
machine-readable and structured format. Medical researchers can
combine genomic data with clinical and environmental information in
a manner that enables statistical analysis and pattern
detection.
About the National Institutes of Health
(NIH)
NIH, the nation's medical research agency, includes
27 Institutes and Centers and is a component of the U.S. Department
of Health and Human Services. NIH is the primary federal agency
conducting and supporting basic, clinical, and translational
medical research, and is investigating the causes, treatments, and
cures for both common and rare diseases. For more information about
NIH and its programs, visit www.nih.gov.
About 2bPrecise
A fully owned subsidiary of Allscripts, 2bPrecise
addresses the challenge of enabling clinical utilization of
‘precision medicine’ data by delivering actionable, interpreted,
and patient-specific information in a readable and computable
format within a provider’s existing clinical workflow, truly
facilitating decision-making at the point of care.
The cloud-based precision-medicine platform
harmonizes genomic, clinical, and lifestyle data and brings
precise, EMR-agnostic, in-workflow interventions that work
seamlessly within existing provider workflow. Learn more at
www.2bPrecisehealth.com.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare
information technology solutions that advance clinical, financial
and operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers to make better decisions and
deliver better care for healthier populations. To learn more, visit
www.allscripts.com, Twitter, YouTube and It Takes A Community: The
Allscripts Blog.
© 2016 Allscripts Healthcare, LLC and/or its
affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other
Allscripts marks are trademarks of Allscripts Healthcare, LLC
and/or its affiliates. All other products are trademarks of their
respective holders, all rights reserved. Reference to these
products is not intended to imply affiliation with or sponsorship
of Allscripts Healthcare, LLC and/or its affiliates.
2bPrecise, the 2bPrecise logo, and other 2bPrecise
marks are trademarks of 2bPrecise, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all
rights reserved. Reference to these products is not intended to
imply affiliation with or sponsorship of 2bPrecise, LLC and/or its
affiliates.
For more information, contact:
Investors:
Seth Frank
312-506-1213
seth.frank@allscripts.com
Media:
Concetta DiFranco
312-447-2466
concetta.difranco@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024